Is therapy-free remission a realistic goal with cladribine tablets in multiple sclerosis? New insights into the mechanism of action and clinical implications of immune reconstitution with cladribine tablets in MS therapy
- DOI
- 10.1007/s00415-025-13530-1
- Published
- 2025-11-27
- Container
- Journal of Neurology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00415-025-13530-1,
title = {Is therapy-free remission a realistic goal with cladribine tablets in multiple sclerosis? New insights into the mechanism of action and clinical implications of immune reconstitution with cladribine tablets in MS therapy},
author = {C. Kleinschnitz and T. Skripuletz and S. Pfeuffer and M. Pawlitzki and P. Rieckmann and I.-K. Penner and J. Knaup and T. Wagner and M. Hübschen and K. Hellwig and R. Pul},
year = {2025},
journal = {Journal of Neurology},
doi = {10.1007/s00415-025-13530-1},
url = {https://doi.org/10.1007/s00415-025-13530-1}
}RIS
TY - JOUR TI - Is therapy-free remission a realistic goal with cladribine tablets in multiple sclerosis? New insights into the mechanism of action and clinical implications of immune reconstitution with cladribine tablets in MS therapy AU - C. Kleinschnitz AU - T. Skripuletz AU - S. Pfeuffer AU - M. Pawlitzki AU - P. Rieckmann AU - I.-K. Penner AU - J. Knaup AU - T. Wagner AU - M. Hübschen AU - K. Hellwig AU - R. Pul PY - 2025 JO - Journal of Neurology DO - 10.1007/s00415-025-13530-1 UR - https://doi.org/10.1007/s00415-025-13530-1 ER -
APA
Kleinschnitz, C., Skripuletz, T., Pfeuffer, S., Pawlitzki, M., Rieckmann, P., Penner, I., Knaup, J., Wagner, T., Hübschen, M., Hellwig, K., & Pul, R. (2025). Is therapy-free remission a realistic goal with cladribine tablets in multiple sclerosis? New insights into the mechanism of action and clinical implications of immune reconstitution with cladribine tablets in MS therapy. Journal of Neurology. https://doi.org/10.1007/s00415-025-13530-1
Source records
- crossref · retrieved 2026-09-25T11:11:40.459Z